
Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: Results from the ISAR-DESIRE 2 trial
Keywords: DES, drug-eluting stent; ISAR, individualizable stent to abrogate restenosis; PES, paclitaxel-eluting stent; PCI, percutaneous coronary intervention; SES, sirolimus-eluting stent; TLR, target lesion revascularizationSirolimus-eluting stent; Restenosis; Di